from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1141c/echA11

LFCtreatmentdescriptionclass of inhibitor

1.828

Amikacinug/mL Amikacintranslation

1.224

Cap5-10ug/mL Capreomycintranslation

3.643

Rox10-50 ug/mL Roxithromycintranslation

0.042

SM2-5 ug/mL Streptomycintranslation

3.261

Tet5-10 ug/mL Tetracyclinetranslation

0.324

Rif0.2-5ug/mL Rifampicintranscription

-0.377

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.089

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.638

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.406

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.789

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.034

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.850

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.552

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.015

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.265

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.675

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.188

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.163

KCN5-20 ug/mL Potassium cyaniderespiration

0.241

NaN30.2-2 mM Sodium aziderespiration

-0.879

Nigericin50 uM Nigericinrespiration

-0.072

TRC10-150 ug/mL Triclosanrespiration

0.513

TRZ10-25 ug/mL Thioridazinerespiration

0.204

Valinomycin0.5-10 uM Valinomycinrespiration

-0.359

ZnSO42 mM ZnSO4respiration

-0.385

menadione6-10 ug/mL Menadionerespiration

-0.387

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.469

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.639

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.508

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.393

NRP_1Non-replicating persistence stage 1dosRassociated

-0.021

Amp0.2mg/mL AmpicillincellWall

-0.140

Cephalexin20-100 ug/mL CephalexincellWall

-0.238

Cerulenin0.32-5 ug/mL CerulenincellWall

0.290

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.098

EMB10-20 ug/mL EthambutolcellWall

-0.060

Eta12-40 ug/mL EthionamidecellWall

-0.068

INH0.2-0.4 ug/mL IsoniazidcellWall

0.325

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.336

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.956

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.041

BZA0.12 mg/mL BenzamidearomaticAmides

0.240

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.375

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.302

H2O24 mM hydrogen peroxideDNAdamaging

0.020

Levo10 ug/mL LevofloxacinDNAdamaging

-0.237

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.001

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.701

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.404

UVUV-irradiationDNAdamaging

-0.818

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.354

Antimycin12.5-50 ug/mL Antimycin A?

-0.162

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.786

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.377

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.864

PA8240.2-2 ug/mL PA-824?

-0.330

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.597

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.244

Verapamil50 uM Verapamil?

0.004

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.017

methoxatin10-20 ug/mL Methoxatin?